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ABSTRACT
Newly developed genome-editing tools, such as the
clustered regularly interspaced short palindromic re-
peat (CRISPR)–Cas9 system, allow simple and rapid
genetic modification in most model organisms and
human cell lines. Here, we report the production and
analysis of mice carrying the inactivation via dele-
tion of a genomic insulator, a key non-coding regu-
latory DNA element found 5′ upstream of the mouse
tyrosinase (Tyr) gene. Targeting sequences flanking
this boundary in mouse fertilized eggs resulted in
the efficient deletion or inversion of large intervening
DNA fragments delineated by the RNA guides. The re-
sulting genome-edited mice showed a dramatic de-
crease in Tyr gene expression as inferred from the
evident decrease of coat pigmentation, thus sup-
porting the functionality of this boundary sequence
in vivo, at the endogenous locus. Several potential
off-targets bearing sequence similarity with each of
the two RNA guides used were analyzed and found
to be largely intact. This study reports how non-
coding DNA elements, even if located in repeat-rich
genomic sequences, can be efficiently and function-
ally evaluated in vivo and, furthermore, it illustrates
how the regulatory elements described by the EN-
CODE and EPIGENOME projects, in the mouse and
human genomes, can be systematically validated.
INTRODUCTION
Non-coding DNA regulatory elements are composed of ar-
rays of DNA–protein binding sites extending over tens to
hundreds of base pairs that are occupied bymultiple groups
of transcription factors. DNA methylation, covalent mod-
ification of histone proteins and DNase I hypersensitivity
profiles allow unbiased identification of such elements as
regions of active chromatin that might be relevant in the
regulation of different genes in a particular tissue or con-
dition. Systematic ChIP-Sequencing (chromatin immuno-
precipitation coupled with massive parallel sequencing) us-
ing antibodies specific for a variety of nuclear factors, ap-
plied to several human cell lines (1) and mouse tissues (2),
served to identify cell type-specific regulatory elements ac-
counting for almost 80% of the non-coding fraction of the
genome. These studies, globally known as the ENCODE
project (Encyclopaedia of DNA Elements; (3)) underline
the rich proportion of functional elements existing within
the non-coding areas of mammalian genomes. The recent
publication of the human EPIGENOME project has pro-
vided additional evidence for the relevance of DNA regula-
tory elements in controlling gene expression (4). However,
many functional experiments are required to unequivocally
demonstrate the links between the observed biochemical
chromatin features and the predicted biological function
(5).
In the past years, the relevance of non-coding regions
has been typically addressed, in vivo, using genomic-type
transgenes (mostly bacterial and yeast artificial chromo-
somes, BACs and YACs; reviewed in (6)) carrying the in-
activation of putative regulatory elements surrounded by
tens to hundreds of kilo bases of genomic sequences of a
suitable endogenous gene or coupled to a reporter gene (7–
11). In this manner, large genomic fragments have been eas-
ily manipulated using homologous recombination in bacte-
ria (12) and yeast (13) and then introduced into the mouse
germline by standard procedures (14–15). However, vari-
ability is often observed between transgenic lines generated
with BAC- or YAC-type transgenes, suggesting that po-
sition effects can influence transgene expression, even on
large constructs (15–21). In addition, not all loci fit in such
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artificial chromosome-type transgenes, for example, large
multi-gene syntenic blocks or gene clusters, whose tran-
scriptional regulation programs during development are co-
ordinated (22).
Inmice and rats, non-coding regulatory elements can also
be inactivated at the endogenous locus by gene targeting in
embryonic stem (ES) cells, a routine and standardised pro-
cess that relies on low-frequency homologous recombina-
tion events (23). Genetic manipulation of the endogenous
locus will often result in a phenotype that truly reflects the
relevance of the targeted sequence, either a coding gene or a
regulatory element, mimicking disease conditions found in
man (24–27). However, generating mouse models by gene
targeting in ES cells is a lengthy procedure requiring several
breeding steps to eventually bring the targeted allele from
ES cells to the desired genetic background to investigate the
phenotype. Furthermore, the presence of repetitive DNA
sequences, often flanking regulatory elements, complicate
the design of targeting vectors and can ultimately lead to
suboptimal gene targeting (28). Indeed, we previously at-
tempted and failed to inactivate the Tyr 5′ regulatory DNA
element analyzed in this current study by standard gene tar-
geting in mouse ES cells, likely because of the repetitive na-
ture of the DNA sequences surrounding this element ((29)
and Victoria Tovar and Lluis Montoliu, unpublished).
After more than two decades of basic research (reviewed
in (30)), RNA-guided genome editing has emerged as an
alternative technique to achieve a wide variety of targeted
genetic manipulations and CRISPR–Cas9-mediated muta-
genesis has rapidly become the preferred approach in an-
imal transgenesis (31). The combined microinjection of a
single guide RNA (sgRNA) molecule specific for the target
sequence and the RNA encoding the CRISPR-associated
protein 9 (Cas9) drives the generation of double-strand
breaks (DSBs) at the target site (32) with a frequency as high
as 95% in mouse embryos (33). Thereafter, when a DSB is
resolved through the non-homologous end-joining (NHEJ)
repair pathway, several small insertion and deletions (indels)
are introduced, often disrupting the coding sequence of a
targeted gene. In the presence of a DNA template, either
single or double stranded, subtle genetic modifications can
be introduced through homologous recombination. Multi-
ple target sites in the genome can be edited simultaneously
by co-delivery of Cas9 and several sgRNAs (33). Further-
more, when two adjacent genomic sites are targeted, poten-
tially triggering simultaneous DSBs, loss of the intervening
DNA sequence can occur. Consequently, this approach can
also be applied for producing large and targeted deletions
(34).
Tyrosinase is the first and main enzyme in the melanin
biosynthesis pathway (35–36). Mutations in Tyr, the gene
encoding tyrosinase, result in hypopigmented phenotypes
due to reduced melanin production in the two cell types
where this gene is specifically expressed, namely, neural
crest-derived melanocytes and retinal pigment epithelium
(RPE) cells, derived from the optic cup (37). Tyr null mu-
tants are unable to producemelanin and result in albinism, a
rare genetic condition described in nearly all animals. In hu-
mans, mutations in the orthologous TYR locus are associ-
ated with oculocutaneous albinism type I (OCA1), the com-
monest form of albinism in Europe andAmerica and one of
the 18 types of albinism (and genes) known for this group
of rare diseases, whose common features, besides variable
hypopigmentation, are the profound visual abnormalities
(38).
Here, we report the inactivation, through deletion, of a
key non-coding regulatory element, a genomic boundary lo-
cated in the 5′ region∼12 kb upstream of the mouse Tyr lo-
cus (7,29,39,40) using a CRISPR–Cas9 approach. We pro-
duced several founder mice using a combination of Cas9
and two sgRNAs targeting unique sequences flanking the
Tyr 5′ boundary. The genome-editedmice we obtained lack-
ing this DNA sequence displayed a clear and robust pheno-
type, thus supporting the in vivo relevant function of this
non-coding element at the endogenous locus.
MATERIALS AND METHODS
CRISPR–Cas9 plasmid and RNA preparation
Repeat-masked sequences in the region 5′ upstream of the
mouse Tyr gene were scanned using the online tool crispr.
mit.edu. Top scoring sgRNA sequences and related off-
target sites were retrieved. CRISPR–Cas9 reagents were
prepared as reported (41). Briefly, the Cas9 coding sequence
was obtained from the hCas9 vector (Addgene, #41815)
and PCR amplified with the oligonucleotides T7-Cas9Fw
(which includes the T7 RNA polymerase promoter) and
Cas9Rv (Supplementary Table S1). One microgram of pu-
rified PCR product was used for RNA in vitro transcrip-
tion using the mMessage mMachine Ultra T7 Kit (Am-
bion). Two complementary oligonucleotides were designed
carrying 20 bp of the target site and Esp3I-compatible over-
hangs as reported previously, annealed in vitro and cloned
by Golden Gate Cloning in the Esp3I sites of the sgRNA
expression vector MLM3636 (Addgene, #43860). A PCR
product of the sgRNAcassette was used forRNA transcrip-
tion using T7 RNA polymerase (Roche) with no further
capping or polyA-tailing reactions. Both Cas9 and sgRNA
were purified using Nucaway Spin Columns (Ambion) and
rehydrated in sterile RNAse-free microinjection buffer (1
mM Tris–HCl pH 7.5, 0.1 mM EDTA pH 7.5).
CRISPR–Cas9 RNA microinjection into mouse fertilized
eggs
For microinjection, 35–50 ng/l of Cas9 mRNA and 60–
90 ng/l of each sgRNA species were prepared in ster-
ile RNAse-free microinjection buffer (1 mM Tris–HCl
pH 7.5; 0.1 mM EDTA pH 7.5), centrifuged for 30 min
at 14 000 x g at 4◦C and kept on ice until use. RNA
molecules were co-microinjected into the cytoplasm of
B6CBAF2 (Harlan; originated from B6CBAF1/OlaHsd)
fertilized eggs. RNA was also delivered into the pronu-
cleus to visually confirm the microinjection step. Addi-
tionalmousemanipulationswere performed following stan-
dard procedures (43). Founder animals were bred to al-
bino outbred HsdWin:NMRI (Harlan) mice, the refer-
ence albino genetic background used in all previous Tyr
transgenic mouse studies (7). TYRINS5 mouse lines were
maintained in albino outbredHsdWin:NMRI background.
Whole-mounted retinae from adult mice were prepared as
described (9). Melanin contents in skin and eye extracts
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were estimated as reported before (43), measuring it as op-
tical density (OD) at 492 nm (44) and expressed per gram
of fresh tissue. Statistical analyses (One-way ANOVA with
post-hocBonferroni correction) were carried out using IBM
SPSS Statistics 21 software.
In this study, all genome-edited mouse lines were named
as TYRINS5# followed by a number corresponding to
the founder they were derived from. However, the cor-
rect nomenclature for these newly generated mouse lines
is stock-TyremXLmon, where ‘X’ is the corresponding ordinal
number for each TYRINS5 mouse line, as recommended
by the International Committee on Standardized Genetic
Nomenclature forMice (Mouse Genome Informatics: http:
//www.informatics.jax.org/mgihome/nomen/index.shtml).
All the procedures that required the use of animals com-
plied with Spanish and European legislation concerning
vivisection and the use of genetically modified organisms,
and the CSIC Ethics Committees on Animal Experimenta-
tion approved the protocols.
T7 endonuclease I assay (T7 assay)
A 400–700 bp fragment centred on the target site was am-
plified by PCR in a 25 l reaction. The PCR product was
melted and cooled in a thermocycler as reported (41) to
favor the formation of heteroduplexes. Ten microliters of
PCR product were digested with 0.3 l of T7 Endonuclease
I (NEB) in a 20 l reaction for 30 min at 37oC and resolved
on a 2% TBE–agarose gel. All oligonucleotides used in this
study are detailed in Supplementary Table S1.
RESULTS
Deletion of the Tyr 5′ boundary results in a dramatic reduc-
tion in coat color pigmentation
Weaimed to delete themouseTyr 5′ boundary element (Fig-
ure 1; boxes A and B; (29)) by CRISPR–Cas9-mediated
DNA cleavage. This regulatory element is also marked
by reported H3K4me1 and p300 ChIP profiles in mouse
melanocytes (Figure 1B; (42)). To obtain the desired 1.2 kb
deletion, we microinjected pigmented (B6CBAF2) mouse
fertilized eggs with Cas9 mRNA and two sgRNAs (5′0
and 5′5, Figure 1C) targeting flaking sequences located up-
stream and downstream of the mouse Tyr 5′ boundary el-
ement following described procedures (41). We obtained a
total of 64 live pups (Table 1), four of them already showing
obvious alterations in coat color pigmentation (Figure 2A–
D), suggesting that both copies of the Tyr 5′ boundary ele-
ment have been deleted. Each of these four founder mouse
lines initially showed distinct levels and patterns of pigmen-
tation, likely representing variable mosaicism. Indeed, upon
breeding each founder animal with albino outbred Hsd-
Win:NMRI mice (our reference albino strain used in all
previous Tyr functional studies; (7)), all F1 progenies in-
heriting the edited alleles showed the same and robust phe-
notype, which presented as a uniform weakly-pigmented
light grey coat color (Figure 2E–H). We termed each of
these genome-edited mouse lines as TYRINS5 followed
by an ordinal number (#N) corresponding to the founder
mouse (see ‘Materials andmethods’ section for the standard
nomenclature of all genome-edited mice).
Deletions of variable size produced by targeting adjacent se-
quences
Chromosomal deletions could be observed in 19 (30%)
mouse lines by systematic T7 endonuclease I assay (T7 as-
say, see ‘Materials and methods’ section) and PCR evalua-
tion of all 64 foundermice generated (Table 2). Notably, and
most likely as a consequence of NHEJ, partial deletions as
well as deletions spanning outside the targeted region were
also observed in six mouse lines: TYR5INS5#3, #13, #18b,
#57, #60 and #62 (Figure 1B). For example, in founder
TYR5INS5#13, the deletion extends approximately 500 bp
upstreamof the sgRNA5′0. In othermouse lines, large dele-
tions appear to have been generated by a single DSB fol-
lowed by extensive exonuclease activity. In fact, we could
not observe indels associated with the sgRNA 5′5 site af-
ter sequencing the partial deletions in founder mouse lines
TYRINS5#8 and TYRINS5#18b (Supplementary Figure
S1). Regarding the mouse lines carrying deletions of the
expected size (TYRINS5#6, #11, #18a, #20, #21, #30,
#35, #48 and #53; Figure 1B), subsequent and system-
atic cloning and sequencing approaches confirmed that
the deletion breakpoint occurred in close proximity to
the sgRNA target sites and, frequently, 3 bp upstream
to the Protospacer Adjacent Motif (PAM) as previously
reported (32). In two cases (founder mice TYRINS5#18
and TYRINS5#60, Figure 1C), we observed two distinct
deletions (TYRINS5#18a and #18b; TYRINS5#60a and
#60b) occurring in the same founder animal, which later
segregated independently in the F1 generation, resulting in
a total of twenty one different deletions generated.We chose
ten of the twenty one mouse lines carrying deletions pro-
duced byCRISPR–Cas9 for further analysis (TYRINS5#8,
#11, #13, #18a, #18b, #30, #35, #50 and #60a and #60b).
All eight founder mice carrying deletions transmitted these
ten edited alleles through the germ line (Table 3). We could
confirm a Mendelian inheritance pattern in four of these
10 mouse lines, whereas mosaicism was observed in the re-
maining mouse lines (45).
DSBs generated by Cas9 at adjacent sites can also cause
chromosomal inversions
The inversion of the intervening DNA is another possi-
ble resolution of two distal DSBs as previously reported
in cultured cells (46) or in zebrafish (47). We therefore
investigated whether chromosomal inversions could have
been produced in our experimental model. The majority
of founder mice generated in our experimental approach
(52/64, 81%) carried mutations affecting one of the two tar-
get sites, or both, or were associated with deletions or in-
versions (Table 2). Indeed, we could detect specific inver-
sion of the targeted sequence in seven animals by PCR us-
ing a forward primer mapping outside the targeted region
(LCRdelFw) in combination with a second forward primer
mapping inside the targeted region (67 Fw) (Figure 3A and
B and Supplementary Figure S2). Cloning and sequencing
procedures confirmed these results. The inversion break-
points were found in the immediate proximity of sgRNA
target sites and were often accompanied by indels (Fig-
ure 3C). To date, we have obtained germ line transmission of
these inverted alleles only for two of the six tested founders
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Figure 1. ThemouseTyr locus in its genomic location. Experimental design to delete the Tyr 5′ boundary element by CRISPR–Cas9-mediatedmutagenesis
and chromosomal deletions found in founder animals. (A) ThemouseTyr locus in its genomic landscape flanked byNox4 andGrm5 genes. TheTyrLCR (7)
which includes the Tyr 5′ boundary (29) is shown as a red box at ∼12 kb from the Tyr promoter. (B) UCSC Genome browser tracks displaying H3K4me1
and p300 ChIP peaks around the Tyr locus in mouse melanocytic melan-a cells, adapted from reported results (42). (C) Above: Position of the Tyr 5′
boundary core elements (A and B boxes, shown in red (29,39) and CRISPR sgRNA 5′0 and sgRNA 5′5 target sites, spaced 1.2 kb with respect to the
Tyr locus). Simultaneous DSBs triggered by Cas9 nuclease at the sgRNA sites 5′0 and 5′5 will produce a 1.2 kb deletion. Below: Position and size of the
deletions obtained. For each TYR5INS edited mouse line, the deleted DNA region is indicated as a black box. In addition to the deletion of the expected
size (1.2 kb), larger and smaller deletions were also observed. Two different deletions occurred in founders #18 and #60, here indicated as #18a, #18b and
#60a, #60b.
Table 1. CRISPR–Cas9 RNA microinjection into B6CBAF2 fertilized eggs
RNA concentration
Microinjected mouse
fertilized eggs
Transferred mouse
embryos (%
microinjected)
Number of fosters
used
Live pups obtained
(% transferred)
Positive mouse lines
(deletions) (% live pups)
35 ng/l Cas9 163 86 (52%) 5 31 (36%) 7 (23%)
60 ng/l sgRNA
50 ng/l Cas9 225 99 (44%) 7 33 (33%) 12 (36%)
90 ng/l sgRNA
TOTAL 388 185 (47%) 12 64 (35%) 19 (30%)
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Figure 2. Alterations in coat color pigmentation in founder animals and their progeny. (A) Coat color alterations of founder mouse TYRINS5#11 (left)
with a non-transgenic pigmented littermate. (B) Founder mouse TYRINS5#18 (left) is shown with a non-transgenic littermate: a lighter coat color is
observed compared with founder TYRINS5#11, indicating a weaker degree of mosaicism. (C) Founder mouse TYRINS5#35 shows hypopigmented
patches in the belly. (D) Founder mouse TYRINS5#60, strongly pigmented and, likely suggesting a higher degree of mosaicism. (E) F1 animals obtained
by breeding founder TYRINS5#13 with albino outbred HsdWin:NMRI wild-type mice. A strong reduction of coat color pigmentation is observed in mice
carrying the deletion of the Tyr 5′ boundary element. Notably, pigment is not fully absent, as in the case of albino mice (indicated with yellow arrows),
but dramatically reduced when compared with pigmented, wild-type animals. (F) All F1 progeny obtained from founder TYRINS5#18 (shown in B) show
uniformly reduced pigmentation, indicating that both copies of the Tyr 5′ boundary element were deleted in this founder. (G) F1 mouse derived from
founder TYRINS5#19, carrying an inversion of the intervening Tyr 5′ sequence. In this case, the inversion was transmitted to just one individual, showing
the same phenotype as those carrying a deletion of the same DNA sequence (panels E, F and H). (H) F1 progeny of the founder TYRINS5#60 (shown in
D). The individuals that inherited the deletion of the Tyr 5′ boundary element show a clear and robust reduction in coat color pigmentation.
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Table 2. Types of mutations observed among the 64 TYRINS5 founder mice generated
RNA concentration
T7 Endo I assaya
sgRNA 5′0
T7 Endo I assaya
sgRNA 5′5 Deletions Inversions No mutations
35 ng/l Cas9 11/31 (35%) 18/31 (58%) 7/31 (23%) 2/31 (6%) 8/31 (26%)
60 ng/l sgRNA
50 ng/l Cas9 12/33 (36%) 22/33 (67%) 12/33 (36%) 5/33 (15%) 4/33 (12%)
90 ng/l sgRNA
Total 23/64 (36%) 40/64 (62%) 19/64 (30%) 7/64 (11%) 12/64 (19%)
aT7 Endo I assay = T7 Endonuclease I assay.
Table 3. Germline transmission of TYRINS5 mouse lines carrying deletions and inversions
Founder mouse line Type of mutation
Edited mice/all F1 mice
(percentage)
Germline transmission, inheritance
typea
TYRINS5#8 0.7 kb deletion 14/35 (40%) Yes, Mendelian
TYRINS5#11 1.2 kb deletion 1/27 (4%) Yes, non-Mendelian
TYRINS5#13 1.2 kb deletion 8/26 (31%) Yes, non-Mendelian
TYRINS5#18a 1.2 kb deletion 6/9 (66%) Yes, Mendelian
TYRINS5#18b 0.7 kb deletion 3/9 (33%) Yes, Mendelian
TYRINS5#30 1.2 kb deletion 3/37 (8%) Yes, non-Mendelian
TYRINS5#35 1.2 kb deletion 3/21 (14%) Yes, non-Mendelian
TYRINS5#50 1.2 kb deletion 7/23 (30%) Yes, Mendelian
TYRINS5#60a 1.2 kb deletion 2/21 (10%) Yes, non-Mendelian
TYRINS5#60b 1.2 kb deletion 6/21 (29%) Yes, non-Mendelian
TYRINS5#19 1.2 kb inversion 2/17 (12%) Yes, non-Mendelian
TYRINS5#23 1.2 kb inversion 0/14 (0%) No
TYRINS5#30 1.2 kb inversion 0/37 (0%) No
TYRINS5#31 1.2 kb inversion 0/42 (0%) No
TYRINS5#41 1.2 kb inversion 7/17 (41%) Yes, Mendelian
TYRINS5#60 1.2 kb inversion 0/21 (0%) No
aMendelian inheritance tested by chi-square test with the help of Mendel program (45).
(Table 3), and only in one case through a Mendelian ra-
tio. These results suggest that this genomic rearrangement
might have occurred later in embryo development, there-
fore associating with an increased mosaicism and resulting
in weaker germ line contribution. Interestingly, we observed
alterations in coat color pigmentation in the two mouse
lines carrying the inverted Tyr 5′ boundary (Figure 2H), re-
sembling the phenotype seen inmice carrying deleted alleles
(Figure 2E-G). This altered coat color pattern is also simi-
lar to that of the chinchilla-mottled (Tyrc-m) mousemutant, a
spontaneous Tyr mutant allele that carries a gross genomic
inversion involving theTyr 5′ upstream region including the
Tyr 5′ boundary element (48,49).
Assessing the overall mutagenesis rate
Ourmain goal was to produce a targeted deletion by trigger-
ing two simultaneous DSBs at adjacent sites in the genome.
Nevertheless, to assess the overall mutagenesis efficiency
we achieved in this CRISPR–Cas9 genome editing proto-
col in vivo, we decided to systematically analyze the DNA
sequence at both target sites (5′0 and 5′5) for all 64 pups
obtained (Figure 1B and Table 2). We amplified DNA se-
quences flanking each of the two sgRNA target sites by
PCR and digested the resulting PCR products with the
mismatch-sensitive T7 Endonuclease I enzyme (‘T7 assay’;
as described in (41)) (Supplementary Figure S3). Analysis
of agarose electrophoresis gels indicated that 36% of the an-
imals presented indel mutations at the sgRNA 5′0 site and
62% carried indels at the sgRNA 5′5 site (Table 2). In ad-
dition, 25% of the founder animals were double positive in
the two T7 assays, in the absence of large deletions, suggest-
ing that DSBs and the associated repair mechanisms may
have not occurred synchronously. As many as 44% of the
edited foundermice generated showed the typical CRISPR–
Cas9 scar at only one of the two targeted sites (as was later
confirmed by cloning and sequencing of PCR products).
Twelve animals (19%) did not show any gross mutations
that could be detected by the T7 assay. Next, we cloned and
sequenced each targeted region. Most of the observed in-
dels accumulated around the PAMmotif. We also observed
larger deletions induced by a single DSB, as previously re-
ported (50). In summary, considering all animals analyzed,
we could identify a variety of edited alleles triggered by sgR-
NAs 5′0 and 5′5 and, in many cases, co-segregating in the
same mosaic founder mice, with the median size for the ob-
served deletion being 9 bp (Supplementary Figure S4).
Analysis of potential off-target sites
Several independent laboratories have reported that
CRISPR–Cas9 approaches in vitro can efficiently trigger
DSBs at DNA regions with sequences that share simi-
larity with the intended target site (51–53). We therefore
evaluated whether our experimental design might have
triggered alterations in other similar genomic locations.
Thus, we retrieved genomic regions carrying high sequence
similarity with either one of the two sgRNA target sites
used according to the predicted sequences given by the
algorithm we employed (online tool crispr.mit.edu) (Table
4). The three most similar predicted DNA sequences
corresponding to each of the two selected sgRNAs (5′0
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Figure 3. Chromosomal inversions generated by targeting two adjacent sites. (A) Scheme of the mouse Tyr locus. (B) Simultaneous cleavage at the sgRNA
sites 5′0 and 5′5 can also trigger the inversion of the intervening DNA. Inversions can be detected using two oligonucleotides (LCRdelFw and 67 Fw)
annealing on the same DNA strand. (C) Confirmation by cloning and Sanger sequencing of the different chromosomal inversion observed. Indels are
found at the junction. CRISPR target sites are shown in bold, PAM motif is shown in red. The four asterisks indicate the inversion breakpoint. Deleted
nucleotides are indicated as dashes; inserted bases are shown in blue.
and 5′5) were amplified by PCR and analyzed by the T7
assay in all 64 founder animals. The six loci were found
to be mostly unmodified in the vast majority of animals
(Supplementary Figures S5 and S6). We detected faint
digested DNA products in very few animals in the T7 assay
(Supplementary Figures S5 and S6, indicated with arrows);
however, upon cloning and sequencing these selected
PCR products, we failed to detect any obvious off-target
mutation in any of the six additional genomic locations
investigated (Supplementary Figure S7).
An allelic series allows the functional identification of the core
element of the Tyr 5′ boundary
We have obtained multiple mouse lines lacking the spe-
cific intervening DNA region by targeting two adjacent se-
quences flanking the Tyr 5′ boundary element (Figure 1B).
Unexpectedly, we also obtained founder animals in which
the deleted DNA sequence was found to be shorter, where
only a part of the targeted region has been eliminated, or
larger, extending outside the intended region (Figure 1B).
Nevertheless, irrespective of the deleted allele, the observed
coat color phenotype for all these lines is indistinguishable
(Figures 2E–G and 4A). Similarly, melanin contents in skin
and eye extracts are comparable across independent lines
(Figure 4C and D). We therefore decided to compare and
align the DNA sequences of all the different alleles gener-
ated in order to genetically map the core sequence (deleted
in common in all these lines) that would be responsible for
the observed phenotype. The genetic analysis for this allelic
series indicates that a 410 bp sequence (chr7: 94 656 561–94
656 970, mouse genome assembly NCBIm37 mm9) could
be considered the core of the Tyr 5′ boundary element (Fig-
ure 4B). The deletion of additional surrounding DNA se-
quences did not further alter the grey coat color pigmen-
tation already observed in animals carrying smaller DNA
deletions, including this core element. Interestingly, the core
DNA element inferred from this functional genetic analy-
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Figure 4. Genetic mapping of the Tyr 5′ boundary core sequence. (A) F1 individuals from different TYRINS5 mouse lines (indicated below) carrying
deleted alleles of different size but showing comparable coat color patterns. (B) Scheme illustrating a genomic sequence alignment of the distinct deletion
alleles generated in this study, associated with mice displaying the most similar phenotype. The comparison of all deleted sequences allows the identifi-
cation of a core element for the Tyr 5′ boundary sequence (410 bp), shown in red, which encompasses the A and B boxes previously identified (29,39),
and is likely responsible for the correct activation of Tyr in skin melanocytes in vivo. The coordinates of the red core element are indicated (Assembly
NCBIm37/UCSCmm9). These coordinates correspond to chr7:87508051–87508460 in the newest mouse genome assembly GRCm38.p3 mm10. Melanin
contents in the skin (C) and eye (D) of four different TYRINS5 mouse lines. (*P < 0.05, one-way ANOVA with post-hoc Bonferroni correction).
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Table 4. Predicted off-target sites
Target sitea DNA sequenceb Genomic coordinatesc Feature (gene)
5′0 reference GTGTGACAGTGCAAGATAACAGG chr7: 94,656,546 -94,656,568 Intergenic (Tyr)
5′0-OT1 CTGTCACAGAACAAGATAACCGG chr6: 99,084,014 - 99,084,036 intronic (Foxp1)
5′0-OT2 GGGAGACTGTGCAAGATAAGGGG chrX: 69,682,563 - 69,682,585 intronic (Gabra3)
5′0-OT3 TTTTGACAGAGCAAGATAAATGG chr3: 60,502,350 - 60,502,362 intergenic
5′5 reference GTGATAAAACTAGGCAATTTTGG chr7: 94,657,775 - 94,657,797 Intergenic (Tyr)
5′5-OT1 CAGATAAAAGCAGGCAATTTTGG chr1: 9,300,003 - 9,300,025 Intergenic
5′5-OT2 GAGCAAAAACTTGGCAATTTGGG chr19: 31,071,409 - 31,071,431 Intronic (Prkg1)
5′5-OT3 GTATTAAAATGAGGCAATTTGGG chr14: 112,763,119 - 112,763,141 Intergenic
aOT = Off-target.
bNucleotides that differ from the reference sequence at the corresponding target site are shown underlined.
cPAM sequence (NGG) shown in bold Assembly NCBIm37/UCSCmm9.
sis at the endogenous Tyr locus is in good agreement and
largely reflects previous findings obtained in vitro (29,39)
and in vivo (7,9,39) using a variety of experimental strate-
gies and transgenes. We further confirmed the similarity of
the obtained mouse phenotypes by measuring the melanin
content in skin and eye extracts whose contents were esti-
mated in 42% and 69% of that of the wild-type pigmented
littermates, respectively (Figure 4C and D). No statistically
significant differences were observed among independent
TYRINS5-edited mouse lines, whereas statistically signif-
icant differences were observed between any of the edited
mouse lines and the wild-type pigmented animals.
Comparative analysis of TYRINS5-edited mice with YAC
Tyr transgenic mice
The comparison of genome-edited mouse lines carrying a
targeted inactivation of the 5′ Tyr boundary (this work)
with other mouse transgenic lines bearing similar dele-
tions within large chromosome-type genomic transgenes re-
veals interesting but fundamental differences. The absence
of the Tyr 5′ boundary element in YRT4 (7), or its tar-
geted deletion in YRT5 (7) and LCR (18) YAC trans-
genic mice, results in a strong reduction of Tyr gene expres-
sion in neural crest-derived melanocytes, as demonstrated
by a dramatic reduction in coat color pigmentation (almost
albino-like), associated with strongly variegated expression
(9) (Figure 5A). In contrast, the reduced coat color phe-
notype observed in all targeted TYRINS5 lines is milder,
uniformly light grey, and without signs of variegation (Fig-
ures 4A and 5A). Additionally, a more severe phenotype
is observed in the eyes of YRT4 and LCR YAC trans-
genic mice, where a profound loss of pigment is obvious in
choroidal melanocytes and strong variegation is observed
at the RPE cell layer (9,18) (Figure 5C). In contrast, the ex-
pression of Tyr at the RPE cell layer appears unaffected in
TYRINS5 mice in all analyzed lines, without signs of var-
iegation, and the loss of Tyr expression in the choroid is
less marked (Figure 5B), as it can also be inferred from eye
melanin content measurements (Figure 4D).
DISCUSSION
Here, we propose a simple strategy to functionally vali-
date the relevance of non-coding regulatory elements in the
mouse genome, in vivo. We have applied CRISPR–Cas9-
mediated mutagenesis tools to inactivate, via deletion, a key
regulatory sequence identified in the mouse Tyr gene (48).
We previously reported a DNAse hypersensitive (HS)
site, located at ∼12 kb 5′-upstream of the mouse Tyr tran-
scription start site (TSS), associated with a melanocyte-
specific enhancer that was required for the correct expres-
sion of the Tyr gene (39). The deletion or inactivation of
this element, in the context of YAC transgenesis, produced
mice displaying variegationwith severely reduced coat color
pigmentation, supporting the notion that this key element
was acting as a Locus Control Region (LCR) (7)). Homolo-
gous sequences to thismouseTyr 5′ element were also found
within the 5′ end of the human TYR locus, suggesting that
mutations in this element could also impair the function of
the human TYR gene (54). Traditional molecular diagnosis
efforts for OCA1 patients regularly fail to detect all TYR
mutations, beyond coding, promoter and limited intronic
DNA sequences routinely explored. Consequently, it has
been repeatedly suggested that mutations in non-coding re-
gions could be responsible for some of these unknown non-
functional TYR alleles (38,55,56). Interestingly, the recent
human epigenome data released for many cellular types, in-
cluding skin melanocytes, describes a regulatory element
(a DNAse HS) located at ∼10 kb 5′ upstream of the hu-
man TYR gene promoter ((4); Supplementary Figure S8) at
the same genomic location as was previously predicted (54).
Until now, the direct relevance of TYR or Tyr regulatory el-
ements could not be adequately studied at the endogenous
loci. Instead, their role had to be inferred from results ob-
tained using diverse standard and chromosome-type trans-
genes in mice (17,35).
Further studies revealed that the Tyr LCR had properties
typical of genomic boundaries or insulators (57), including
the capacity of establishing barriers that prevent spread-
ing of heterochromatin and epigenetic silencing (29), and
enhancer-blocking activity (40). The function of insulators
is rather complex and strictly dependent on the interactions
with other proximal and distal sequences in the genomic
locus (43,58–60). The context-dependent activity of insula-
tors should be therefore characterized in their native chro-
mosomal context by gene targeting. However, the presence
of repetitive sequences surrounding the Tyr 5′ boundary
element (29) invalidated the application of standard gene
targeting approaches. As an alternative, we decided to use
CRISPR–Cas9-mediated mutagenesis to overcome the lim-
itations of classical gene targeting strategies.
4864 Nucleic Acids Research, 2015, Vol. 43, No. 10
Figure 5. Inactivation of the Tyr 5′ boundary element at the endogenous locus and in modified YAC Tyr transgenes. (A) Distinct Tyr mouse models,
both transgenic (YAC YRT4 (7); YAC LCR (18) and genome-edited (TYRINS5) individuals, carrying the inactivation of the Tyr 5′ boundary element
presented along with albino outbred HsdWin:NMRI mice and fully pigmented YAC YRT2 transgenic mice carrying the entire Tyr expression domain
(63). The coat color of LCR and YRT4 YAC transgenic mice is almost indistinguishable from albino mice due to a strongly variegated Tyr expression,
but eyes are pigmented. In contrast, the coat color of the TYRINS5 edited mouse is light gray. (B) Whole-mounted retinae obtained from a TYRINS5
edited mouse. (C) Whole-mounted retinae obtained from aLCR transgenic mouse. Variegation is observed inLCRmice, at the RPE cell layer, whereas
variegation is absent in TYRINS5 mice. In addition, a more severe loss of pigmentation at underlying choroidal melanocytes is observed in LCR as
compared with TYRINS5 mice. Scale bars in (B) and (C) panels correspond to 50 m.
Similar approaches have been recently reported to ad-
dress the role of a distal Sox2 enhancer in mouse ES cells
(5). Endonuclease-mediated deletions, using Transcription
Activator-Like Effector Nucleases (TALENs) and Zinc-
Finger Nucleases (ZFN), have been described in zebrafish
(61). CRISPR–Cas9 was also used to characterize muta-
tions found at the distal enhancer of the TAL1 oncogene
in human tumor cell lines (62). Additionally, mouse mod-
els were generated using CRISPR–Cas9 in mouse ES cells
to reproduce structural variants, including deletions and in-
versions, found in human disease (63).
In this work, we report that defined deletions and in-
versions in non-coding regions can be efficiently gener-
ated in vivo by CRISPR–Cas9 approaches using sgRNAs
directed to adjacent genomic target sites. CRISPR–Cas9
RNA species are injected into fertilized eggswhere they gen-
erate mutations at the target sequences. These mutations
are then efficiently transmitted through the germ line. Us-
ing this strategy, mouse embryos are exposed to a limited
amount of Cas9 nuclease for a short time, thus minimiz-
ing the risk of off-target mutations. Indeed, in our screen,
no undesired mutations were detected at the six genomic
loci highly similar to the targeted sequences under investiga-
tion. In contrast to this, approaches based on the delivery of
CRISPR–Cas9 plasmids to somatic or ES cellsmay increase
the associated risk of off-target mutations since exposure to
the Cas9 nuclease is massive and prolonged (31).
Inactivation of the Tyr 5′ boundary element in genomic-
type transgenes resulted in a severe reduction in coat color
pigmentation, pointing to a relevant role for this non-
coding sequence (7). However, these results were based on
ectopic chromosomal locations, where variables such as
transgene integrity, copy number and integration site could
affect the overall gene expression program (15–21). Because
of this, our vision was to target this 5′ boundary element di-
rectly at theTyr endogenous locus, where we could unequiv-
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ocally link this element to the observed phenotype without
further uncontrolled variables. In actual fact, a comparative
analysis of Tyr expression patterns in YAC Tyr transgenic
mouse lines and TYRINS5 edited lines reveals fundamental
differences in both melanocytes and RPE cells (Figures 4A,
C,D, 5A, B andC). Deleting theTyr 5′ boundary appears to
have amilder effect in skin and choroidal melanocytes and a
more limited impact inRPE cells, suggesting that additional
regulatory elements may be responsible for controlling Tyr
gene expression in RPE cells. Indeed, the presence of RPE-
specific regulatory elements further upstream had been pre-
viously proposed and investigated in mice using BAC Tyr
transgenes engineered with a lacZ reporter gene and vari-
able combinations of Tyr 5′ genomic sequences (64).
The differences found in these two experimental ap-
proaches likely depend on the integration site and highlight
the drawbacks/disadvantages of traditional trangenes, in-
cluding large genomic-type transgenes, particularly when
they lack relevant regulatory elements (7,9). Transgenesis
with intact TyrYAC transgenes such as YRT2 (65), encom-
passing the entire Tyr expression domain, result in mice
that are virtually indistinguishable from wild-type agouti-
pigmentedmice. However, evenwithYRT2 transgenicmice,
it was possible to detect very mild forms of variegation
in RPE cells (Figure 3G in (9)). Therefore, large trans-
genes may behave differently at ectopic integration sites and
may display somewhat different phenotypes compared with
those associated with similar genomic alterations at the en-
dogenous locus. The most common alteration seen in stan-
dard transgenic mice (and one of their most obvious limita-
tions) is variegation, in which not all cells carrying a given
transgene are able to express it adequately at ectopic loca-
tions. Also, variegation is more often observed in plasmid-
type transgenes as compared with genomic-type transgenes
(6). Conversely, targeted inactivation using nucleases allows
unbiased characterization of cell type-specific regulatory el-
ements, as recently achieved in human erythroid cells within
theBCL11A (66) and EZH1 (67) loci. Perhaps more impor-
tantly, inactivation of non-coding elements at their endoge-
nous genomic locations allows, for the first time, investiga-
tion of changes in chromatin marks that may be associated
with the loss of a genomic boundary. For example, our ex-
perimental model can now be used to investigate potential
perturbations in the expression profiles of the neighboring
Nox4 and Grm5 genes, which flank the Tyr locus in both
human and mouse genomes, to assess whether the removal
of a genomic boundary, such as the Tyr 5′ element, disrupts
the expression pattern scenario (Figure 1A). These analy-
ses need to be addressed in homozygous mice. Similarly, the
possible alteration of chromatinmarks around theTyr locus
will have to be addressed in immortalized melanocytes, fol-
lowing experimental approaches described in previous stud-
ies (68).
We have produced several genome-edited mice carrying
deletions of variable size around a non-coding regulatory
element that display a strikingly similar phenotype (Fig-
ure 4A). The alignment of all distinct deletions highlights
the core nucleotides functionally associated with this regu-
latory element (Figure 4B). In just one experiment, we could
genetically map the relevant sequences associated with this
regulatory element. A similar outcome using classical gene
targeting methods would have required multiple indepen-
dent experiments. Hence, the uncertainty and uncontrolled
nature of the deletion breakpoints edited alleles sponta-
neously generated by NHEJ can become a benefit for the
in vivo characterization of non-coding regulatory elements.
In this work, we have investigated the role of the mouse
Tyr 5′ boundary element in its endogenous genomic loca-
tion using a CRISPR–Cas9 approach. A series of deletions
generated in mice allowed us to genetically map the rele-
vant sequences associated with this boundary and to nar-
row down its function in the context of the regulation ofTyr
gene expression. Interestingly, the Tyr 5′ core element de-
tected (Figure 4B) extends beyond the knownAandBboxes
(29,39), and includes potential binding sites for transcrip-
tion factors Lmx1a andLef-1 (as suggested byTRANSFAC
and UniPROBE). Mutant mouse lines for these two tran-
scription factors show alterations in coat color pigmenta-
tion (Montoliu L, Oetting WS, Bennett DC. Color Genes.
April 2015. European Society for Pigment Cell Research.
http://www.espcr.org/micemut), thus suggesting a potential
relevance of these additional protein binding sites within the
Tyr 5′ regulatory element.
All genome-edited mice lacking this boundary displayed
an overall reduction in coat color pigmentation, indicating a
pivotal role for this regulatory element in skin melanocytes.
However, RPE cells appeared largely unaffected, suggest-
ing that this regulatory element is dispensable in this other
cell type that expresses Tyr. These results finally overcome
the variable phenotype traditionally observed with all pre-
vious transgenic Tyr mice based on plasmids or large ge-
nomic constructs. The differences observed between trans-
genic (at ectopic sites) and editing (at the endogenous site)
approaches underscores the power and validity of system-
atic CRISPR–Cas9-mediated mutagenesis to functionally
assess regulatory elements in non-coding sequences that
have been discovered by the ENCODE and EPIGENOME
projects. Moreover, functional analysis of regulatory ele-
ments, now feasible in animal models and cellular models
of human disease, will likely increase our current under-
standing on the origin and underlying mechanisms of many
pathologies of genetic origin.
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